AMRX
NASDAQ
$17.50
Amneal Pharmaceuticals Inc - Class A (AMRX)
Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company is headquartered in Bridgewater, New Jersey.
Sector:
Healthcare
Strong Buy
Target: $18.25 (+4.29%)
Market Cap
$5.44B
Forward P/E
6.30
P/E Ratio
54.57
Free Cash Flow Yield
4.43%
Price Chart
Valuation
Market Cap$5.44B
P/E54.57
Forward P/E6.30
P/S1.80
P/B105.45
Profitability
Total Revenue (TTM)$3.05B
Gross Profit (TTM)$1.19B
EBITDA$491M
Profit Margin8.6%
Operating Margin19.6%
EPS$0.32
Financial Health
Debt-to-Equity-5663.3%
Free Cash Flow Yield4.43%
Growth & Risk
Revenue 5Y CAGR+8.92%
FCF 5Y CAGR-10.41%
Beta (5Y)0.89
Sharpe Ratio2.34